Funding Opportunities and Notices

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts   December 3, 2021 General Notices NCCIH Announces Availability of Frequently Asked Questions (FAQs) for HEAL Sickle Cell Disease Pain Management Funding Opportunities RFA-AT-22-004 and RFA-AT-22-005 (NOT-AT-22-006) National Center for Complementary and Integrative Health Pre-Application Webinar for RFA-CA-21-060, RFA-CA-21-061, and RFA-CA-21-062: "The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers" (NOT-CA-22-019) National Cancer Institute Pre-Application Webinar for NCI's Innovative Molecular Analysis Technologies (IMAT) Innovative Technologies Funding Opportunities (RFA-CA-22-001, RFA-CA-22-003) (NOT-CA-22-022) National Cancer Institute Request for Information on Proposed Updates and Long-Term Considerations for the NIH Genomic Data Sharing Policy (NOT-OD-22-029) Office of the Director, NIH Notices of Changes to Funding Opportunities Notice of Change to Eligibility Information in PAR-21-351 "NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)" (NOT-AG-22-002) National Institute on Aging Notice of Early Expiration of PAR-19-078, Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)" (NOT-AI-22-005) National Institute of Allergy and Infectious Diseases Notice of Early Expiration of PAR-19-079, Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)" (NOT-AI-22-006) National Institute of Allergy and Infectious Diseases Notice of Early Expiration of PA-19-077, Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)" (NOT-AI-22-009) National Institute of Allergy and Infectious Diseases Notice of NIAMS' Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" (NOT-AR-21-028) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice to Extend NOT-AR-20-005, "Notice of Special Interest: Promoting research opportunities on HIV/AIDS in NIAMS" (NOT-AR-22-013) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Clarification of Award Budget Instructions for Specific Aims in RFA-ES-21-007, Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional) (NOT-ES-22-004) National Institute of Environmental Health Sciences Notice of NICHD Participation in NOT-OD-20-054, "Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars" (NOT-HD-21-049) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of NICHD Participation in NOT-OD-20-055, "Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards" (NOT-HD-21-050) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of Change to Key Dates for PAR-19-261, "Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)" (NOT-HD-21-054) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of Change in Eligible Organizations for PAR-21-312, "Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed)" (NOT-HG-22-005) National Human Genome Research Institute Notice of Change of the Locus of Review and Application Types Allowed for PAR-22-035, "Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)" (NOT-MH-22-075) National Institute of Mental Health Notice of Change of the Locus of Review and Application Types Allowed for PAR-22-036, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)" (NOT-MH-22-076) National Institute of Mental Health Notice of Participation of the National Institute of Nursing Research (NINR) in PAR-21-287, Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) (NOT-NR-22-007) National Institute of Nursing Research Notice of Correction to Award Information for RFA-RM-22-006, " Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)" (NOT-RM-22-005) Office of Strategic Coordination (Common Fund) Notice of Change to Participant Eligibility, Participant Costs and Other Attachments to Funding Opportunity Announcement PAR-21-339, Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Program (R25) (NOT-TR-22-010) National Center for Advancing Translational Sciences Notices of Intent to Publish Notice of Intent to Publish a Funding Opportunity Announcement for NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) (NOT-DA-21-084) National Institute on Drug Abuse Notice of Intent to Publish a Funding Opportunity Announcement for NIDCD National Human Ear Resource Network (U24) (NOT-DC-22-006) National Institute on Deafness and Other Communication Disorders Notice of Intent to Publish a Funding Opportunity Announcement for NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed) (NOT-NS-22-039) National Institute of Neurological Disorders and Stroke National Institute on Drug Abuse National Institute of Dental and Craniofacial Research Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Human and Non-Human Primate Brain (UM1 Clinical Trial Not Allowed) (NOT-NS-22-045) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Mouse Brain (UM1 Clinical Trial Not Allowed) (NOT-NS-22-046) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Research on Community Level Interventions to Prevent Firearm and Related Violence, Injury and Mortality (NOT-OD-22-028) Office of Behavioral and Social Sciences Research Notices of Special Interest Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA (NOT-AA-22-002) National Institute on Alcohol Abuse and Alcoholism Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity (NOT-AI-21-082) National Institute of Allergy and Infectious Diseases Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery (NOT-AI-22-014) National Institute of Allergy and Infectious Diseases Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology (NOT-CA-22-003) National Cancer Institute Notice of Special Interest (NOSI): Research in the Chemistry and Pharmacology of Addictive Drugs (NOT-DA-23-002) National Institute on Drug Abuse Notice of Special Interest (NOSI): KC Donnelly Externship (Admin Supp Clinical Trial Not Allowed) (NOT-ES-22-003) National Institute of Environmental Health Sciences Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional) (NOT-OD-22-030) Office of Research on Women's Health National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Nursing Research Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) (NOT-OD-22-031) Office of Research on Women's Health National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Nursing Research Office of Disease Prevention Notice of Special Interest (NOSI): Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional) (NOT-OD-22-032) National Institutes of Health John E. Fogarty International Center National Center for Complementary and Integrative Health National Cancer Institute National Human Genome Research Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Office of AIDS Research Office of Disease Prevention Office of Research on Women's Health Notice of Special Interest (NOSI): Availability of Administrative Supplements for Helping to End Addiction Long-term (HEAL) Initiative awardees to make data Findable, Accessible, Interoperable, and Reusable (FAIR) through the HEAL Data Ecosystem (NOT-OD-22-033) Office of the Director, NIH National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health National Institute of Neurological Disorders and Stroke Funding Opportunities Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) (PAR-21-356) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Heart, Lung, and Blood Institute National Institute of Allergy and Infectious Diseases Application Receipt Date(s): September 25, 2023 Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) (PAR-22-031) National Institute of Mental Health National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Application Receipt Date(s): Multiple dates, see announcement. Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) (PAR-22-032) National Institute of Mental Health National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Application Receipt Date(s): January 07, 2025 NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) (PAR-22-065) National Institute of General Medical Sciences Application Receipt Date(s): June 14, 2024 Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required) (PAR-22-068) National Institute of Dental and Craniofacial Research Application Receipt Date(s): Multiple dates, see announcement. High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) (PAR-22-069) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): October 30, 2024 Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) (PAS-22-074) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): May 07, 2025 Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) (RFA-AG-22-030) National Institute on Aging Application Receipt Date(s): January 10, 2022 National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U2C - Clinical Trial Not Allowed) (RFA-DK-21-027) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): March 08, 2022 New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) (RFA-DK-21-030) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): Multiple dates, see announcement. Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed) (RFA-DK-21-032) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): March 24, 2022 Coordinating Unit for the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U24 - Clinical Trial Not Allowed) (RFA-DK-21-035) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): March 08, 2022 Conformance with the Egg Regulatory Program Standards (U2F) [Clinical Trial Not Allowed] (RFA-FD-22-006) Food and Drug Administration Application Receipt Date(s): January 31, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed) (RFA-HD-23-010) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): March 30, 2022 Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center (UM2 Clinical Trial Optional) (RFA-HD-23-020) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Mental Health Application Receipt Date(s): March 31, 2022 Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) (RFA-HD-23-021) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Mental Health Application Receipt Date(s): March 31, 2022 BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) (RFA-NS-22-011) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Office of Behavioral and Social Sciences Research Application Receipt Date(s): October 11, 2024   NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892